Clinical trial
Treatment and Outcome of Early Onset Bipolar Disorder
NCT00048802 · Northwell Health, Other · Completed
Key facts
| NCT number | NCT00048802 |
|---|---|
| Title | Treatment and Outcome of Early Onset Bipolar Disorder |
| Official title | Treatment and Outcome of Early Onset Bipolar Disorder |
| Lead sponsor | Northwell Health, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Lithium, Olanzapine, Divalproex, Risperidone, Quetiapine, Ziprasidone, Aripriprazole |
| Enrollment | 40 |
| Start date | Aug 1, 2002 |
| Primary completion | Aug 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Nov 13, 2002 |
| Last update posted | Jan 22, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: